The spread of the Omicron variant is pushing COVID towards being an endemic disease that humanity can live with, although it remains a pandemic for now, the EU's drug watchdog said Tuesday.
Jan 11, 2022
0
22
Millions of people around the world have received two shots of Sinovac, a Chinese-manufactured inactive vaccine that is used in 48 countries to help reduce transmission rates of COVID-19.
Jan 20, 2022
0
225
A booster dose of the Pfizer–BioNTech vaccine (BNT162b2) against SARS-CoV-2 after an initial two doses of either the CoronaVac inactivated virus vaccine or Pfizer–BioNTech mRNA vaccine is shown to provide protection against ...
Jan 24, 2022
0
27
As COVID numbers fall and mandates lift, the question remains: Is it possible to avoid trade-offs between returning to pre-pandemic lifestyles and an uptick in COVID-19-related deaths?
Apr 4, 2022
2
164
A new study using serum from human blood samples suggests neutralizing antibody levels produced by two-dose mRNA vaccines against the original and early variants of the SARS-CoV-2 virus wane substantially over time, and offer ...
Mar 1, 2022
0
198
As the SARS-CoV-2 virus replicates and spreads, errors in its genetic code can lead to changes in the virus. On 26 November 2021, the World Health Organization designated the variant B.1.1.529, first identified in South Africa, ...
Dec 20, 2021
0
53
Virologists thought they had seen the worst of SARS-CoV-2's variants when delta emerged in the spring of 2021, but by fall a new one was in circulation with a slew of spike protein mutations that took the scientific community ...
The immune system develops a high-quality antibody response after three encounters with the coronavirus spike protein. These antibodies are also capable of neutralizing omicron efficiently. This applies to people who are ...
Feb 3, 2022
0
374
The world registered a record-high average of more than three million coronavirus cases a day between January 13 and 19, fuelled by the Omicron variant, an AFP tally showed Thursday.
Jan 20, 2022
0
34
UBC researchers are the first in the world to conduct a molecular-level structural analysis of the omicron variant spike protein.
Dec 23, 2021
0
230
